The Innovator IBD Breakout Opportunities ETF (BOUT) top stock holdings include Enliven Therapeutics, Apogee Therapeutics, and Bicara Therapeutics. The top 25 BOUT holdings ordered by weight make up 98.13% of the total fund. BOUT is an equity fund in the broad equity category that invests in publicly traded companies and other investments, focused on strategy strategies within the North America region. This page includes a complete BOUT stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.
Top 25 BOUT Holdings
BOUT Geographic Exposure
BOUT's largest geographic exposure is United States at 174.1%, followed by Panama at 2.0%.
BOUT Currency Exposure
BOUT is exclusively exposed to USD.
BOUT Sector Exposure
BOUT's largest sector exposure is Financials at 93.1%, followed by Health Care at 61.4%.
BOUT Industry Exposure
BOUT's largest industry exposure is Banks at 59.5%, followed by Biotechnology at 45.7%.
Oil, Gas & Consumable Fuels
Semiconductors & Semiconductor Equipment
BOUT Sub-Industry Exposure
BOUT's largest sub-industry exposure is Diversified Banks at 45.9%, followed by Biotechnology at 45.7%.
Investment Banking & Brokerage
Electrical Components & Equipment
Internet & Direct Marketing Retail
Asset Management & Custody Banks
Oil & Gas Storage & Transportation
BOUT Coupon Exposure
BOUT's largest coupon exposure is 2-4 at 0.7%.
BOUT Maturity Exposure
BOUT's largest maturity exposure is 10-15 at 0.7%.